| Literature DB >> 26096737 |
James P Trujillo1,2, Niels J H M Gerrits2,3, Chris Vriend2,3,4, Henk W Berendse3,5, Odile A van den Heuvel2,3,4, Ysbrand D van der Werf1,2,3.
Abstract
OBJECTIVE: Parkinson's disease (PD) often entails impairments of executive functions, such as planning. Although widely held that these impairments arise from dopaminergic denervation of the striatum, not all executive functions are affected early on, and the underlying neural dynamics are not fully understood. In a combined longitudinal and cross-sectional study, we investigated how planning deficits progress over time in the early stages of PD compared to matched healthy controls. We used functional magnetic resonance imaging (fMRI) to identify accompanying neural dynamics.Entities:
Keywords: cognitive load; executive function; frontoparietal; frontostriatal; functional connectivity
Mesh:
Substances:
Year: 2015 PMID: 26096737 PMCID: PMC5033031 DOI: 10.1002/hbm.22873
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
Figure 1Study design and task paradigm. A. Study design and exclusion process. B. Task paradigm. On the left, an example from the out‐of‐scanner version. In the middle, an example of the counting condition for the in‐scanner version. On the right, an example of the planning condition from the in‐scanner version. Possible user responses are indicated beneath corresponding example images, and response type is indicated below this. All text has been translated from Dutch to English for the purpose of this figure. ToL‐in: in‐scanner version of the Tower of London. ToL‐out: out‐of‐scanner version of the Tower of London. PD: Parkinson's disease. HC: healthy control.
MNI coordinates for ROI analyses
| Planning | Task‐load | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| L DLPFC | −40 | 28 | 30 | −42 | 34 | 34 |
| R DLPFC | 32 | 34 | 42 | 44 | 32 | 32 |
| L caudate | −12 | 10 | 0 | −16 | 6 | 16 |
| R caudate | 12 | 8 | 0 | 18 | 4 | 16 |
| L IPC | −58 | −38 | 44 | −38 | −66 | 38 |
| R IPC | 48 | −42 | 46 | 50 | −44 | 50 |
L: left, R: right, DLPFC: dorsolateral prefrontal cortex, IPC: inferior parietal cortex.
Mean and standard deviations for demographic and clinical data at follow‐up
| HC ( | PD ( |
| |
|---|---|---|---|
|
| |||
| Age (years) | 58.38 ± 9.67 (40 – 74) | 60.18 ± 8.91 (40 – 76) |
|
| Years between measures | 3.29 ± 1.13 (1.5 – 5.1) | 3.01 ± 0.9 (1.8 – 5.2) |
|
| Gender (% male) | 14 (70.0%) | 11 (64.7%) |
|
| Handedness (% right) | 19 (95.0%) | 14 (82.4%) |
|
| Education | 6.00 ± 1.00 (5 – 7) | 6.00 ± 2 (3 – 7) |
|
|
| |||
| MMSE | 29.00 ± 1.00 (26 – 30) | 28.00 ± 1.50 (24 – 30) |
|
| MMSE‐rΔ | 0.002 ± 0.04 (−0.07 – 0.07) | −0.02 ± 0.05 (−0.07 – 0.08) |
|
| BDI | 2.00 ± 5.25 (0 – 7) | 4.00 ± 8.00 (1 – 15) |
|
| BAI | 0.50 ± 3.25 (0 – 7) | 6.00 ± 8.00 (2 – 25) |
|
| UPDRS‐III | 27.29 ± 7.82 (16 – 40) | ||
| UPDRS‐III‐rΔ | 1.28 ± 4.23 (−0.27 – 16.50) | ||
| Subtype (% mixed/% akinetic) | 4 (23.5%)/13 (76.5%) | ||
| Lateralization (% mixed/% left) | 15 (88.2%)/2 (11.8%) | ||
| Hoehn and Yahr | 2 ± 0.5 (1.5 – 3) | ||
| LEDD | 450 ± 255 (230 – 1760) | ||
|
| |||
| Task performance | 89.5 ± 16.25 (62 – 96) | 82 ± 18.92 (44 – 96) |
|
| Task reaction time (seconds) | 9.94 ± 2.06 (6.88 – 15.29) | 11.11 ± 4.08 (7.5 – 24.8) |
|
| Task performance‐rΔ | −0.01 ± 0.07 (−0.21 – 0.06) | −0.07 ± 0.12 (−0.30 – 0.07) |
|
| Reaction time‐rΔ | −0.05 ± 0.10 (−0.33 – 0.14) | −0.05 ± 0.16 (−0.28 – 0.25) |
|
Education represents Verhage stages; MMSE: mini‐mental state examination; MMSE‐Δ: relative change in MMSE score between baseline and follow‐up; BDI: Beck depression inventory; BAI: Beck anxiety inventory; UPDRS‐III: Unified Parkinson's disease rating scale, motor subscale; UPDRS‐III‐Δ: relative change in UPDRS‐III score between baseline and follow‐up; LEDD: total levodopa equivalent dosage; HC: Healthy controls; PD: Parkinson's disease patients. Significant at a threshold of P = 0.001 (uncorrected) with an extent‐threshold k > 5.
Figure 2Mean activation estimates of planning in ROIs. Solid bars represent the control group, striped bars represent the PD group. On the y‐axis, the mean parameter estimate (beta weight) is given; along the x‐axis, the individual ROIs. PD: Parkinson's disease. DLPFC: dorsolateral prefrontal cortex. IPC: inferior parietal cortex. DLPFC: dorsolateral prefrontal cortex; IPC: inferior parietal cortex.
Figure 3Mean activation estimates of group‐by‐task load for the ROIs. Solid black lines represent the control group, grey dashed lines represent the PD group. Individual plots represent the individual ROIs, with left lateralized regions along the top row and right lateralized regions along the bottom row. Within each plot, the y‐axis represents the mean parameter estimates (beta weight), while the x‐axis denotes the task‐load. DLPFC: dorsolateral prefrontal cortex; IPC: inferior parietal cortex.
Figure 4Correlation with dopamine‐transporter binding ratios and performance over time. On the y‐axis, dopamine‐transporter binding ratios are indicated, while on the x‐axis, the relative accuracy difference is indicated. Negative numbers represent poorer performance at follow‐up compared to baseline, while positive numbers represent better performance at follow‐up compared to baseline. Correlation: r s = 0.69, P = 0.03.